Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition for treating diabetic encephalopathy and its preparation method and application

A technology of diabetic encephalopathy and composition, which is applied in the field of pharmaceutical composition for the treatment of diabetic encephalopathy, and can solve problems such as lack of uniformity

Active Publication Date: 2018-08-03
CHENGDU HUASUN GRP INC LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Diabetic encephalopathy is characterized by cognitive dysfunction, accompanied by a complication of structural and pathophysiological changes in the brain; some scholars have also proposed to name it "diabetes-related cognitive decline", which has not yet been unified

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition for treating diabetic encephalopathy and its preparation method and application
  • A kind of pharmaceutical composition for treating diabetic encephalopathy and its preparation method and application
  • A kind of pharmaceutical composition for treating diabetic encephalopathy and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] The preparation of embodiment 1 pharmaceutical suspension oral liquid of the present invention

[0050]Get Pueraria 12g, Coptis 6g, Scutellaria baicalensis 9g, Dendrobium 12g, Bear bile powder 1.5g, Panax notoginseng powder 3g;

[0051] The experiment used water decoction, Pueraria 12g Coptidis 6g Scutellaria baicalensis 9g Dendrobium 12g was decocted in water and concentrated to a solution of 0.65g / ml, adding bear bile powder and Panax notoginseng powder to make a suspension.

Embodiment 2

[0052] The preparation of embodiment 2 pharmaceutical granules of the present invention

[0053] Take 12g of kudzu root, 6g of berberine, 9g of scutellaria baicalensis, 12g of dendrobium, 1.5g of bear bile, and 3g of notoginseng, extract according to the method in Example 1, concentrate, granulate, and granulate.

Embodiment 3

[0054] The preparation of embodiment 3 pharmaceutical capsules of the present invention

[0055] Pueraria 12g, Coptidis 6g, Scutellaria baicalensis 9g, Dendrobium 12g, bear bile 1.5g, Sanqi 3g were extracted according to the method of Example 1, concentrated, granulated, granulated, and packed into capsules.

[0056] Prove beneficial effect of the present invention by pharmacodynamic test below.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for treating diabetic encephalopathy, which is a preparation prepared from the following raw materials in weight ratio: 12-18 parts of kudzu root, 8-12 parts of berberine, 8-12 parts of Scutellaria baicalensis, 12 parts of dendrobium ‑18 servings, 2‑4 servings of bear bile, 2‑4 servings of Panax notoginseng. The invention also provides the preparation method and application of the pharmaceutical composition. The drug of the present invention has obvious effect in preventing and treating diabetic encephalopathy, which is better than cilostazol, especially the middle dose group is the best. The medicine of the present invention protects microvessels (blood-brain barrier), promotes angiogenesis, improves hippocampal ischemia and hypoxia, and regulates the activity of hippocampal IGF‑1 and PI3K / AKT / CREB signaling pathways.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating diabetic encephalopathy, which belongs to the field of medicines. Background technique [0002] Diabetes (diabetes mellitus, DM) and its complications have become a health issue of public concern, because in recent years, with social and economic development, global diabetes patients have surged far beyond people's expectations, according to statistics from the International Diabetes Federation (IDF) In 2011, the number of diabetic patients in the world was 370 million, and developing countries accounted for 80% of the cases. The prevalence of diabetes in people over 20 years old in my country reached 9.7%, and China has become the country with the largest number of diabetic patients. Diabetes has a long course of disease, many complications, and high medical costs, which have a great impact on patients and society. At present, non-infectious diseases such as diabetes, tumors, and cardi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8984A61P3/10A61P25/28A61K35/413
Inventor 王飞张廷模袁有才
Owner CHENGDU HUASUN GRP INC LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com